Simplify Logo

Full-Time

Sr. Securities Counsel

Posted on 6/25/2024

Twist Bioscience

Twist Bioscience

1,001-5,000 employees

Produces synthetic DNA for biotechnology applications

Biotechnology
Healthcare

Compensation Overview

$200k - $234.3kAnnually

+ Bonus + Equity

Mid, Senior

San Bruno, CA, USA

California-based role.

Category
Legal
Legal & Compliance
Requirements
  • 4+ years of relevant experience at a major law firm, advising public companies on securities law matters
  • Proficient knowledge of SEC and Nasdaq rules
  • Registered to practice in California or be eligible for Registered In-House Counsel (RIHC) status in California
Responsibilities
  • Prepare and review SEC filings, including Form 8-Ks, the proxy statement and related documents, Section 16 filings, Registration Statements (S-1, S-8, and S-3), and Forms 10-Qs and 10-Ks
  • Support Board and Committee meetings, including the drafting, preparation and review of Board meeting materials, minutes, and D&O questionnaires
  • Support Twist’s annual stockholders meeting
  • Support Investor Relations by reviewing press releases, earnings releases, investor presentations, and other materials
  • Advise on equity matters, including equity plan, and compensation issues
  • Ensure compliance with public company legal, securities, and governance requirements, and support the necessary controls, processes and procedures
  • Provide counseling, training and general legal advice to the company on securities laws and requirements, including periodic reporting requirements, Nasdaq listing standards, beneficial ownership reporting requirements, Regulation FD, related party transactions, and insider trading rules
  • Work independently but collaboratively in a fast-paced and collegial team environment
  • Demonstrate sound business and legal judgment, project management and prioritization skills
  • Support M&A and other strategic activities
  • Effective manage outside counsel as needed

Twist Bioscience focuses on DNA synthesis, providing synthetic DNA for applications in biotechnology, pharmaceuticals, and research. Their proprietary platform allows for quick and accurate production of DNA sequences, offering products like genes, oligo pools, and variant libraries. The company stands out by supplying high-quality DNA at competitive prices and handling complex sequences, making them a valuable partner for research projects. Their goal is to support advancements in science and medicine through accessible DNA synthesis.

Company Stage

IPO

Total Funding

$585.6M

Headquarters

South San Francisco, California

Founded

2013

Growth & Insights
Headcount

6 month growth

0%

1 year growth

2%

2 year growth

2%
Simplify Jobs

Simplify's Take

What believers are saying

  • The launch of new products like CHO Express Antibodies and synthetic RNA controls for H5N1 Influenza A demonstrates Twist Bioscience's commitment to innovation and expanding its product portfolio.
  • Significant investments from firms like Brown Advisory Inc. and Dynamic Technology Lab Private Ltd highlight strong market confidence in Twist Bioscience's growth potential.
  • Collaborations with companies like Oxford Nanopore Technologies to advance personalized medicine underscore Twist Bioscience's influence in cutting-edge biotechnological research.

What critics are saying

  • The rapidly evolving synthetic biology and genomics sector requires continuous innovation, which can be resource-intensive and challenging to sustain.
  • High competition in the DNA synthesis market could pressure Twist Bioscience to continually lower prices, potentially impacting profit margins.

What makes Twist Bioscience unique

  • Twist Bioscience's proprietary platform allows for rapid and accurate DNA synthesis, providing instant feedback to customers, which is a significant advantage over traditional methods.
  • Their ability to handle complex DNA sequences that are difficult to work with makes them a valuable partner for advanced research projects.
  • Twist Bioscience offers a diverse range of products, including synthetic RNA controls and DNA data storage solutions, setting them apart from competitors who may focus on narrower product lines.

Help us improve and share your feedback! Did you find this helpful?

INACTIVE